Sign in

CIK 0001109354

  • Large accelerated filer

BRUKER CORP

Sign in to watch
Ticker
BRKR
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043110160
Phone
+1 978-663-3660
Business address
40 MANNING RD, BILLERICA, MA, 01821
Former names
BRUKER BIOSCIENCES CORP, BRUKER DALTONICS INC

Securities

  • BRKR Common Stock Nasdaq
  • BRKRP 6.375% Mandatory Convertible Preferred Stock, Series A Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$105,740
in 1 filing

Net −$105,740. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Munch Mark −$106K EXEC VP&PRES BRUKER NANO INC. sold 1% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-05-19 LAUKIEN FRANK H CEO, President Purchase +3,200 $26.13 $84K 37,789,051
2017-05-18 LAUKIEN FRANK H CEO, President Purchase +35,000 $26.33 $921K 37,785,851
2017-05-17 LAUKIEN FRANK H CEO, President Purchase +38,000 $26.11 $992K 37,750,851
2017-05-16 LAUKIEN FRANK H CEO, President Purchase +1,920 $25.88 $50K 37,712,851
2017-05-07 Munch Mark Exec VP&Pres Bruker Nano Inc. Shares withheld for taxes −1,716 $25.66 $44K 61,425
2017-03-17 LAUKIEN FRANK H CEO, President Purchase +4,300 $23.34 $100K 37,710,931
2017-03-13 LAUKIEN FRANK H CEO, President Purchase +2,300 $23.74 $55K 37,706,631
2017-02-24 Lenggenhager Rene President, BioSpin Group Option exercise +3,539 $22.46 $79K 14,576
2017-02-24 Lenggenhager Rene President, BioSpin Group Sale +3,539 $23.93 $85K 11,037
2017-02-24 Lenggenhager Rene President, BioSpin Group Option exercise · Stock option (right to buy) −3,539 10,620
2017-02-18 MATTACCHIONE ANTHONY L Senior Vice President & CFO Shares withheld for taxes −1,237 $24.64 $30K 11,868
2017-02-16 LAUKIEN JOERG C Director Option exercise +3,500 $12.55 $44K 15,212,295
2017-02-16 LAUKIEN JOERG C Director Option exercise · Stock Option-right to purchase −3,500 3,500
2017-01-05 Fesik Stephen W. Director Grant or award +4,577 4,577
2017-01-05 Friend Cynthia M Director Grant or award +4,577 4,577
2017-01-05 VAN INGEN CHRIS Director Grant or award +4,577 4,577
2017-01-05 Kastner Marc A Director Grant or award +4,577 4,577
2017-01-05 KNISS RICHARD Director Grant or award +4,577 40,753
2017-01-05 LINTON WILLIAM A Director Grant or award +4,577 51,327
2017-01-05 Martin Gilles Gerard Jean Director Grant or award +4,577 4,577

Page 29 of 39 · 771 trades